Baird Medical Investment Holdings (BDMD) Other Non-Current Assets (2023 - 2025)
Baird Medical Investment Holdings' (BDMD) quarterly Other Non-Current Assets came in at $7.1 million in Q4 2025, down 11.32% year-on-year from $8.0 million in Q4 2024, and down 14.85% on a QoQ basis from $8.4 million in Q2 2025.
Baird Medical Investment Holdings (BDMD) Other Non-Current Assets (2023 - 2025) Analysis & Trends
Baird Medical Investment Holdings (BDMD) has 3 years of Other Non-Current Assets data on file, last reported at $7.1 million in Q4 2025.
- On a quarterly basis, Other Non-Current Assets fell 11.32% year-over-year to $7.1 million in Q4 2025; TTM through Dec 2025 was $7.1 million, a 11.32% decrease from a year earlier, with the FY2025 full-year figure at $7.1 million, down 11.32% from the prior year.
- Other Non-Current Assets for Q4 2025 stood at $7.1 million, down from $8.4 million in the prior quarter.
- Over the last five years, Other Non-Current Assets for BDMD reached as high as $8.4 million in Q2 2025 and fell as low as $7.1 million in Q4 2025.
- Historically, Other Non-Current Assets has averaged $7.8 million across 3 years, with a median of $7.9 million in 2023.
- Across the five-year window, Other Non-Current Assets rose 4.19% in 2024 and fell 11.32% in 2025, its largest moves.
- Year by year, Other Non-Current Assets stood at $7.7 million in 2023, then gained by 4.19% to $8.0 million in 2024, then decreased by 11.32% to $7.1 million in 2025.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $7.1 million in Q4 2025, $8.4 million in Q2 2025, and $8.0 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 285.90 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 828.89 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 164.00 Mn |
| 10 | Baird Medical Investment Holdings | 30.57 Mn | 30.04 Mn | - | 7.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.11 Mn |
| Jun 30, 2025 | 8.35 Mn |
| Dec 31, 2024 | 8.02 Mn |
| Dec 31, 2023 | 7.70 Mn |